Clinical trial

A Positron Emission Tomography (PET) Study to Evaluate Dopamine D2 and D3 Receptor Occupancy by SIPI6398

NCT07626034

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-08-01

PhasePHASE1 / PHASE2

Study timeline

Study start (estimated)2026-08-01Date precision: month

Registry last updated2026-06-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophrenia Disorderunresolved

Interventions

SIPI6398 TabletsDRUG

Sponsors & collaborators

Shanghai Zhongze Therapeutics Co., Ltd.lead sponsor

Yale Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07626034 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.